MENLO PARK, Calif. (AP) — Adverum Biotechnologies Inc. (ADVM) on Wednesday reported a loss of $14.5 million in its first quarter.

The Menlo Park, California-based company said it had a loss of 23 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.

Adverum Biotechnologies shares have more than doubled since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.41, an increase of 15% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ADVM at

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.